HGH FRAG176-191

Product Name:

HGH 176-191

Chemical Information:

• Molecular Formula: C78H123N23O22S2
• Molecular Weight: 1815.08 g/mol
• Sequence: H-Phe-Leu-Arg-Ile-Val-Gln-Cys(1)-Arg-Ser-Val-Glu-Gly-Ser-Cys(1)-Gly-Phe-OH
• Molecular Structure:

Description:

HGH 176–191 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (HGH). It is commonly utilized in biochemical research involving peptide fragment analysis and structure-function characterization. In controlled laboratory settings, this peptide is studied for its involvement in metabolic pathway modeling and peptide interaction dynamics under defined experimental conditions. This material is supplied in lyophilized powder form and is intended strictly for in vitro research and analytical use.

Research Applications:

HGH 176–191 is utilized in controlled research environments to support investigation of:

• Metabolic pathway modeling and peptide-fragment interaction analysis
• Structure-function relationships of C-terminal HGH-derived peptides
• Peptide interaction dynamics in lipid-associated cellular models
• Stability, degradation, and analytical profiling in assay-based systems

All research applications are conducted in non-human, non-clinical experimental settings.

Storage and Handling:

• Store lyophilized powder at -20°C until use.
• Once reconstituted, store at 2-8°C and use promptly.
• Maintain aseptic techniques during laboratory handling.

Product Specifications:

• Purity: ≥99% (HPLC Certified)
• Appearance: Lyophilized white powder
• Solubility: Soluble in suitable laboratory agents

Compliance Notice:

HGH 176-191 is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. This product has not been evaluated by the FDA. Misuse of this product is strictly prohibited and may violate federal, state, or local laws. By purchasing this product, buyer represents and warrants that it will be used only for in vitro research purposes.